SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Earnings & Estimates
USA - NYSE:SGFY - US82671G1004 - Common Stock
30.49 USD
+0.02 (+0.07%)
30.49 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 610.6M 21.68% | 653.1M 6.96% | 805.5M 23.33% | 1.042B 29.36% | 1.227B 17.75% | 1.545B 25.92% | 1.824B 18.06% | 2.134B 17.00% | 2.477B 16.07% | 2.849B 15.02% | 3.25B 14.08% | |
| EBITDA YoY % growth | 95.9M 11.51% | 127.8M 33.26% | 162.8M 27.39% | 284.26M 74.61% | 339.01M 19.26% | 429.73M 26.76% | 509.08M 18.47% | 595.68M 17.01% | 691.15M 16.03% | 795.09M 15.04% | 906.98M 14.07% | |
| EBIT YoY % growth | 33.6M 68.00% | 86M 155.95% | 109M 26.74% | 35.292M -67.62% | 68.544M 94.22% | 385.15M 461.90% | 466.04M 21.00% | 554.06M 18.89% | 650.86M 17.47% | 756.13M 16.17% | 869.24M 14.96% | |
| Operating Margin | 5.50% | 13.17% | 13.53% | 3.39% | 5.59% | 24.93% | 25.55% | 25.96% | 26.28% | 26.54% | 26.75% | |
| EPS YoY % growth | N/A | 0.11 -1.96% | -0.32 -390.91% | 0.32 200.72% | 0.56 73.26% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.07 214.75% | 0.09 -89.38% | 0.09 109.92% | 0.08 142.08% | 0.07 -3.70% | 0.12 37.14% | 0.10 8.57% | 0.10 15.15% |
| Revenue Q2Q % growth | 245.25M 13.28% | 278.06M 12.94% | 264.77M 89.39% | 253.47M 24.86% | 289.45M 18.02% | 332.55M 19.60% | 309.07M 16.73% | 296.75M 17.07% |
| EBITDA Q2Q % growth | 67.264M 112.19% | 78.735M 51.12% | 73.335M 1,933.37% | 71.253M -62.87% | 81.133M 20.62% | 97.807M 24.22% | 88.314M 20.43% | 85.364M 19.80% |
| EBIT Q2Q % growth | 36.822M 168.77% | 32.708M 133.63% | 32.776M 157.70% | 32.674M -76.34% | 11.526M -68.70% | 16.116M -50.73% | 19.992M -39.00% | 21.012M -35.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -0.20 -253.85% | 0.06 | -0.26 | -463.11% |
| Q3 2022 Q2Q % growth | -0.90 -850.00% | 0.09 | -0.99 | -1,114.20% |
| Q2 2022 Q2Q % growth | 0.84 | 0.10 | 0.74 | 761.79% |
| Q1 2022 Q2Q % growth | -0.06 57.14% | 0.05 | -0.11 | -229.11% |
| Q4 2021 Q2Q % growth | 0.13 205.86% | 0.03 | 0.10 | 377.88% |
| Q3 2021 Q2Q % growth | 0.12 | 0.02 | 0.10 | 488.24% |
| Q2 2021 Q2Q % growth | 0.00 | 0.04 | -0.04 | -100.00% |
| Q1 2021 Q2Q % growth | -0.14 | -0.02 | -0.12 | -648.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 203M 232.24% | 228.99M | -25.99M | -11.35% |
| Q3 2022 Q2Q % growth | 139.8M -29.82% | 242.83M | -103.03M | -42.43% |
| Q2 2022 Q2Q % growth | 246.2M 15.70% | 252.02M | -5.82M | -2.31% |
| Q1 2022 Q2Q % growth | 216.5M 20.28% | 216.94M | -440K | -0.20% |
| Q4 2021 Q2Q % growth | 61.1M -68.42% | 176.66M | -115.56M | -65.41% |
| Q3 2021 Q2Q % growth | 199.2M 28.77% | 188.11M | 11.09M | 5.90% |
| Q2 2021 Q2Q % growth | 212.8M 62.82% | 186.77M | 26.03M | 13.94% |
| Q1 2021 Q2Q % growth | 180M 36.67% | 168.93M | 11.07M | 6.55% |
| Q4 2020 Q2Q % growth | 193.5M 45.16% | 192.55M | 950K | 0.49% |
| Q3 2020 Q2Q % growth | 154.7M 20.58% | % | ||
| Q2 2020 Q2Q % growth | 130.7M -1.73% | % | ||
| Q1 2020 Q2Q % growth | 131.7M 22.85% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -51.79% | 0% | -45.52% |
| Revenue | 0% | -0.81% | 0% | -1.51% |